Innovation, Research
Ribonexus: Overcoming resistance to cancer treatments
… in funds with AdBio partners, Crédit Mutuel Innovation and Pierre Fabre. Although it was originally called Aglaia … molecules that targeted the eIF4F complex provided by Pierre Fabre’s laboratory, after a licence agreement was … in funds with AdBio partners, Crédit Mutuel Innovation and Pierre Fabre. Although it was originally called Aglaia …
Published on: